Business
Currency:USD
2024/Q2
Stock NameRevenueRatio
Business of developing engineered IgM antibodies for the treatment of cancer and autoimmune and1.25M100.00%
Region
Currency:USD
2023/FY
Stock NameRevenueRatio
United States2.13M100.00%